Stock News

Crown Castle Intl N (CCI) Stake Raised by Parsons Capital Management Inc; Acceleron Pharma (XLRN) Stock Declined While Putnam Investments Decreased Its Holding by $597,744

Crown Castle International Corp. (NYSE:REIT) Logo

Parsons Capital Management Inc increased its stake in Crown Castle Intl Corp N (CCI) by 57.11% based on its latest 2017Q4 regulatory filing with the SEC. Parsons Capital Management Inc bought 6,099 shares as the company’s stock rose 1.95% while stock markets declined. The institutional investor held 16,779 shares of the real estate investment trusts company at the end of 2017Q4, valued at $1.86M, up from 10,680 at the end of the previous reported quarter. Parsons Capital Management Inc who had been investing in Crown Castle Intl Corp N for a number of months, seems to be bullish on the $43.54B market cap company. The stock increased 2.28% or $2.34 during the last trading session, reaching $104.96. About 2.76M shares traded. Crown Castle International Corp. (NYSE:CCI) has risen 17.78% since April 23, 2017 and is uptrending. It has outperformed by 6.23% the S&P500.

Putnam Investments Llc decreased its stake in Acceleron Pharma Inc (XLRN) by 33.39% based on its latest 2017Q4 regulatory filing with the SEC. Putnam Investments Llc sold 14,232 shares as the company’s stock declined 5.40% with the market. The institutional investor held 28,396 shares of the biological products (no diagnostic substances) company at the end of 2017Q4, valued at $1.21M, down from 42,628 at the end of the previous reported quarter. Putnam Investments Llc who had been investing in Acceleron Pharma Inc for a number of months, seems to be less bullish one the $1.65 billion market cap company. The stock increased 1.07% or $0.38 during the last trading session, reaching $35.97. About 163,324 shares traded. Acceleron Pharma Inc. (NASDAQ:XLRN) has risen 45.87% since April 23, 2017 and is uptrending. It has outperformed by 34.32% the S&P500.

Parsons Capital Management Inc, which manages about $157.98M and $898.02M US Long portfolio, decreased its stake in Duke Energy Corp New (NYSE:DUK) by 6,119 shares to 14,704 shares, valued at $1.24M in 2017Q4, according to the filing. It also reduced its holding in Park City Group Inc (NASDAQ:PCYG) by 35,400 shares in the quarter, leaving it with 118,175 shares, and cut its stake in Exxon Mobil Corp (NYSE:XOM).

Since February 21, 2018, it had 0 buys, and 2 sales for $2.03 million activity. $1.95M worth of stock was sold by Brown Jay A. on Wednesday, February 21.

Investors sentiment decreased to 1.24 in Q4 2017. Its down 0.34, from 1.58 in 2017Q3. It worsened, as 43 investors sold CCI shares while 214 reduced holdings. 84 funds opened positions while 235 raised stakes. 368.81 million shares or 2.36% less from 377.71 million shares in 2017Q3 were reported. Shelton has invested 0.03% in Crown Castle International Corp. (NYSE:REIT). 131,660 were reported by Apg Asset Nv. Bokf Na stated it has 88,253 shares or 0.27% of all its holdings. Usca Ria Limited Liability Corporation stated it has 0.13% of its portfolio in Crown Castle International Corp. (NYSE:REIT). Moneta Gp Advsr Lc has invested 0% in Crown Castle International Corp. (NYSE:REIT). Sumitomo Mitsui Asset Company Ltd has invested 0.05% of its portfolio in Crown Castle International Corp. (NYSE:REIT). Sei Investments Com stated it has 0.25% of its portfolio in Crown Castle International Corp. (NYSE:REIT). Walleye Trading Limited Liability Corporation invested in 0.01% or 13,861 shares. Factory Mutual Insur Company has invested 0.45% in Crown Castle International Corp. (NYSE:REIT). Bessemer Grp Inc Inc accumulated 2,987 shares. America First Inv Advsrs Ltd Liability holds 62 shares or 0% of its portfolio. Comerica Bancorporation reported 128,876 shares or 0.09% of all its holdings. Moreover, Williams Jones & Limited Com has 2.02% invested in Crown Castle International Corp. (NYSE:REIT). 8.56 million were accumulated by Cap Intl Investors. The Guernsey-based Bluecrest Cap Ltd has invested 0.13% in Crown Castle International Corp. (NYSE:REIT).

Among 21 analysts covering Crown Castle International Corp (NYSE:CCI), 14 have Buy rating, 0 Sell and 7 Hold. Therefore 67% are positive. Crown Castle International Corp had 63 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Overweight” rating by Morgan Stanley given on Thursday, August 24. The rating was maintained by Cowen & Co with “Buy” on Tuesday, July 18. The rating was maintained by SunTrust with “Buy” on Wednesday, October 18. Cowen & Co maintained the shares of CCI in report on Monday, April 25 with “Outperform” rating. Suntrust Robinson initiated the shares of CCI in report on Thursday, February 25 with “Buy” rating. SunTrust initiated it with “Buy” rating and $107 target in Tuesday, September 13 report. The firm earned “Buy” rating on Friday, January 26 by Guggenheim. Oppenheimer downgraded Crown Castle International Corp. (NYSE:REIT) on Sunday, October 15 to “Hold” rating. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, November 29 report. The firm has “Buy” rating by Cowen & Co given on Thursday, October 19.

Since December 15, 2017, it had 0 insider buys, and 13 insider sales for $7.84 million activity. On Tuesday, April 3 Rovaldi Christopher sold $134,395 worth of Acceleron Pharma Inc. (NASDAQ:XLRN) or 3,500 shares. 37,500 shares were sold by POPS RICHARD F, worth $1.55 million on Tuesday, March 6. $182,363 worth of Acceleron Pharma Inc. (NASDAQ:XLRN) was sold by Kumar Ravindra. Quisel John D also sold $46,232 worth of Acceleron Pharma Inc. (NASDAQ:XLRN) shares. The insider Sherman Matthew L sold 4,600 shares worth $176,772. The insider MCLAUGHLIN KEVIN F sold $153,792.

Investors sentiment decreased to 1.09 in 2017 Q4. Its down 0.72, from 1.81 in 2017Q3. It is negative, as 24 investors sold XLRN shares while 32 reduced holdings. 14 funds opened positions while 47 raised stakes. 38.14 million shares or 1.07% more from 37.73 million shares in 2017Q3 were reported. Eventide Asset Limited Com accumulated 653,900 shares. Barclays Public Limited Com has invested 0% in Acceleron Pharma Inc. (NASDAQ:XLRN). Moreover, Great Point Prtn Ltd Llc has 1.25% invested in Acceleron Pharma Inc. (NASDAQ:XLRN) for 173,124 shares. Proshare Ltd holds 0.01% or 29,941 shares. 95,380 are held by United Automobile Association. Westfield Mngmt Communication Limited Partnership reported 1.51 million shares or 0.49% of all its holdings. Cornerstone Capital Mgmt Hldgs Limited Liability invested in 17,083 shares or 0.01% of the stock. Quantitative Mgmt Lc has 5,100 shares for 0% of their portfolio. Moreover, Cormorant Asset Mngmt Ltd Liability Corporation has 0.33% invested in Acceleron Pharma Inc. (NASDAQ:XLRN). The New Jersey-based Lord Abbett & Llc has invested 0.01% in Acceleron Pharma Inc. (NASDAQ:XLRN). Credit Suisse Ag reported 37,844 shares. Farallon Mngmt Ltd Liability Company has 0.38% invested in Acceleron Pharma Inc. (NASDAQ:XLRN). Hillhouse Cap Mgmt Limited accumulated 0.5% or 700,000 shares. 28,396 are owned by Putnam Invs Limited. American Grp Incorporated has invested 0% in Acceleron Pharma Inc. (NASDAQ:XLRN).

Putnam Investments Llc, which manages about $89.35 billion and $44.83 billion US Long portfolio, upped its stake in Fortive Corp by 695,817 shares to 2.24 million shares, valued at $162.06 million in 2017Q4, according to the filing. It also increased its holding in Devon Energy Corp (NYSE:DVN) by 2.64M shares in the quarter, for a total of 2.65M shares, and has risen its stake in Cisco Systems Inc (NASDAQ:CSCO).

Among 16 analysts covering Acceleron Pharma (NASDAQ:XLRN), 12 have Buy rating, 1 Sell and 3 Hold. Therefore 75% are positive. Acceleron Pharma had 40 analyst reports since August 13, 2015 according to SRatingsIntel. H.C. Wainwright initiated the shares of XLRN in report on Monday, January 8 with “Buy” rating. The stock of Acceleron Pharma Inc. (NASDAQ:XLRN) earned “Market Perform” rating by Oppenheimer on Tuesday, June 13. The firm has “Hold” rating by Oppenheimer given on Friday, June 23. Oppenheimer initiated Acceleron Pharma Inc. (NASDAQ:XLRN) on Tuesday, December 13 with “Outperform” rating. The stock has “Neutral” rating by Janney Capital on Thursday, December 17. Morgan Stanley initiated it with “Overweight” rating and $50 target in Thursday, August 13 report. The firm earned “Hold” rating on Thursday, November 2 by RBC Capital Markets. The rating was reinitiated by Oppenheimer on Monday, February 1 with “Outperform”. Citigroup upgraded the shares of XLRN in report on Thursday, March 2 to “Buy” rating. On Wednesday, March 28 the stock rating was initiated by H.C. Wainwright with “Buy”.

Crown Castle International Corp. (NYSE:REIT) Ratings Chart

Leave a Reply

Your email address will not be published. Required fields are marked *